Story perspectives

U.S. Disease Funding Deals Spark Data Sovereignty Concerns in Africa

3/14/2026

Summary

Story summary

U.S. agreements in Africa promise funding for disease programs but require access to data and pathogen samples, prompting concerns about unequal exchanges.
Zimbabwe withdrew from a $367 million deal over provisions, citing risks of supplying raw materials without equitable benefits.
Similar issues have emerged in Zambia and Kenya, where proposed deals could compromise data protection.
Scholars urge fair partnerships and data sovereignty, advocating negotiations through organizations like the African Union.

1 of 1

Story summary

U.S. agreements in Africa promise funding for disease programs but require access to data and pathogen samples, prompting concerns about unequal exchanges.
Zimbabwe withdrew from a $367 million deal over provisions, citing risks of supplying raw materials without equitable benefits.
Similar issues have emerged in Zambia and Kenya, where proposed deals could compromise data protection.
Scholars urge fair partnerships and data sovereignty, advocating negotiations through organizations like the African Union.